Global Adeno-Associated Virus (AAV) Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 131

Published Date: 25 Jan 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Adeno-Associated Virus (AAV) Gene Therapy market size was valued at USD 1684.4 million in 2023 and is forecast to a readjusted size of USD 2966.6 million by 2030 with a CAGR of 8.4% during review period.

The Global Info Research report includes an overview of the development of the Adeno-Associated Virus (AAV) Gene Therapy industry chain, the market status of Central Nervous System Diseases (Luxturna, Zolgensma), Ocular Diseases (Luxturna, Zolgensma), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Adeno-Associated Virus (AAV) Gene Therapy.

Regionally, the report analyzes the Adeno-Associated Virus (AAV) Gene Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Adeno-Associated Virus (AAV) Gene Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Adeno-Associated Virus (AAV) Gene Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Adeno-Associated Virus (AAV) Gene Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Luxturna, Zolgensma).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Adeno-Associated Virus (AAV) Gene Therapy market.

Regional Analysis: The report involves examining the Adeno-Associated Virus (AAV) Gene Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Adeno-Associated Virus (AAV) Gene Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Adeno-Associated Virus (AAV) Gene Therapy:
Company Analysis: Report covers individual Adeno-Associated Virus (AAV) Gene Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Adeno-Associated Virus (AAV) Gene Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Central Nervous System Diseases, Ocular Diseases).

Technology Analysis: Report covers specific technologies relevant to Adeno-Associated Virus (AAV) Gene Therapy. It assesses the current state, advancements, and potential future developments in Adeno-Associated Virus (AAV) Gene Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Adeno-Associated Virus (AAV) Gene Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Adeno-Associated Virus (AAV) Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Luxturna
    Zolgensma
    Others

Market segment by Application
    Central Nervous System Diseases
    Ocular Diseases
    Liver-directed Diseases
    Other Hereditary Diseases

Market segment by players, this report covers
    Creative Biolabs
    Affinia Therapeutics
    Spark Therapeutics
    AGC Biologics
    StrideBio
    SIRION Biotech
    Neurophth Biotechnology
    Belief BioMed
    BiBo Biopharma Engineering Co., LTD.
    Beihai Kangcheng
    PackGene Biotech
    Sarepta Therapeutics
    Carbon BioSciences
    Kelonia Therapeutics
    Roche
    Remedium Bio

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Adeno-Associated Virus (AAV) Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Adeno-Associated Virus (AAV) Gene Therapy, with revenue, gross margin and global market share of Adeno-Associated Virus (AAV) Gene Therapy from 2019 to 2024.
Chapter 3, the Adeno-Associated Virus (AAV) Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Adeno-Associated Virus (AAV) Gene Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Adeno-Associated Virus (AAV) Gene Therapy.
Chapter 13, to describe Adeno-Associated Virus (AAV) Gene Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Adeno-Associated Virus (AAV) Gene Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Adeno-Associated Virus (AAV) Gene Therapy by Type
        1.3.1 Overview: Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Luxturna
        1.3.4 Zolgensma
        1.3.5 Others
    1.4 Global Adeno-Associated Virus (AAV) Gene Therapy Market by Application
        1.4.1 Overview: Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Central Nervous System Diseases
        1.4.3 Ocular Diseases
        1.4.4 Liver-directed Diseases
        1.4.5 Other Hereditary Diseases
    1.5 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size & Forecast
    1.6 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast by Region
        1.6.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Creative Biolabs
        2.1.1 Creative Biolabs Details
        2.1.2 Creative Biolabs Major Business
        2.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.1.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Creative Biolabs Recent Developments and Future Plans
    2.2 Affinia Therapeutics
        2.2.1 Affinia Therapeutics Details
        2.2.2 Affinia Therapeutics Major Business
        2.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.2.4 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Affinia Therapeutics Recent Developments and Future Plans
    2.3 Spark Therapeutics
        2.3.1 Spark Therapeutics Details
        2.3.2 Spark Therapeutics Major Business
        2.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.3.4 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Spark Therapeutics Recent Developments and Future Plans
    2.4 AGC Biologics
        2.4.1 AGC Biologics Details
        2.4.2 AGC Biologics Major Business
        2.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.4.4 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 AGC Biologics Recent Developments and Future Plans
    2.5 StrideBio
        2.5.1 StrideBio Details
        2.5.2 StrideBio Major Business
        2.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.5.4 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 StrideBio Recent Developments and Future Plans
    2.6 SIRION Biotech
        2.6.1 SIRION Biotech Details
        2.6.2 SIRION Biotech Major Business
        2.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.6.4 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 SIRION Biotech Recent Developments and Future Plans
    2.7 Neurophth Biotechnology
        2.7.1 Neurophth Biotechnology Details
        2.7.2 Neurophth Biotechnology Major Business
        2.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.7.4 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Neurophth Biotechnology Recent Developments and Future Plans
    2.8 Belief BioMed
        2.8.1 Belief BioMed Details
        2.8.2 Belief BioMed Major Business
        2.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.8.4 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Belief BioMed Recent Developments and Future Plans
    2.9 BiBo Biopharma Engineering Co., LTD.
        2.9.1 BiBo Biopharma Engineering Co., LTD. Details
        2.9.2 BiBo Biopharma Engineering Co., LTD. Major Business
        2.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.9.4 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments and Future Plans
    2.10 Beihai Kangcheng
        2.10.1 Beihai Kangcheng Details
        2.10.2 Beihai Kangcheng Major Business
        2.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.10.4 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Beihai Kangcheng Recent Developments and Future Plans
    2.11 PackGene Biotech
        2.11.1 PackGene Biotech Details
        2.11.2 PackGene Biotech Major Business
        2.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.11.4 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 PackGene Biotech Recent Developments and Future Plans
    2.12 Sarepta Therapeutics
        2.12.1 Sarepta Therapeutics Details
        2.12.2 Sarepta Therapeutics Major Business
        2.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.12.4 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.13 Carbon BioSciences
        2.13.1 Carbon BioSciences Details
        2.13.2 Carbon BioSciences Major Business
        2.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.13.4 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Carbon BioSciences Recent Developments and Future Plans
    2.14 Kelonia Therapeutics
        2.14.1 Kelonia Therapeutics Details
        2.14.2 Kelonia Therapeutics Major Business
        2.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.14.4 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Kelonia Therapeutics Recent Developments and Future Plans
    2.15 Roche
        2.15.1 Roche Details
        2.15.2 Roche Major Business
        2.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.15.4 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Roche Recent Developments and Future Plans
    2.16 Remedium Bio
        2.16.1 Remedium Bio Details
        2.16.2 Remedium Bio Major Business
        2.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
        2.16.4 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Remedium Bio Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Adeno-Associated Virus (AAV) Gene Therapy by Company Revenue
        3.2.2 Top 3 Adeno-Associated Virus (AAV) Gene Therapy Players Market Share in 2023
        3.2.3 Top 6 Adeno-Associated Virus (AAV) Gene Therapy Players Market Share in 2023
    3.3 Adeno-Associated Virus (AAV) Gene Therapy Market: Overall Company Footprint Analysis
        3.3.1 Adeno-Associated Virus (AAV) Gene Therapy Market: Region Footprint
        3.3.2 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Type Footprint
        3.3.3 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2030)
    6.2 North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2030)
    6.3 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
        6.3.1 North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
        7.3.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2030)
    9.2 South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2030)
    9.3 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
        9.3.1 South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
    11.2 Adeno-Associated Virus (AAV) Gene Therapy Market Restraints
    11.3 Adeno-Associated Virus (AAV) Gene Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Adeno-Associated Virus (AAV) Gene Therapy Industry Chain
    12.2 Adeno-Associated Virus (AAV) Gene Therapy Upstream Analysis
    12.3 Adeno-Associated Virus (AAV) Gene Therapy Midstream Analysis
    12.4 Adeno-Associated Virus (AAV) Gene Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Creative Biolabs Company Information, Head Office, and Major Competitors
    Table 6. Creative Biolabs Major Business
    Table 7. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 8. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Creative Biolabs Recent Developments and Future Plans
    Table 10. Affinia Therapeutics Company Information, Head Office, and Major Competitors
    Table 11. Affinia Therapeutics Major Business
    Table 12. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 13. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Affinia Therapeutics Recent Developments and Future Plans
    Table 15. Spark Therapeutics Company Information, Head Office, and Major Competitors
    Table 16. Spark Therapeutics Major Business
    Table 17. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 18. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Spark Therapeutics Recent Developments and Future Plans
    Table 20. AGC Biologics Company Information, Head Office, and Major Competitors
    Table 21. AGC Biologics Major Business
    Table 22. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 23. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. AGC Biologics Recent Developments and Future Plans
    Table 25. StrideBio Company Information, Head Office, and Major Competitors
    Table 26. StrideBio Major Business
    Table 27. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 28. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. StrideBio Recent Developments and Future Plans
    Table 30. SIRION Biotech Company Information, Head Office, and Major Competitors
    Table 31. SIRION Biotech Major Business
    Table 32. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 33. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. SIRION Biotech Recent Developments and Future Plans
    Table 35. Neurophth Biotechnology Company Information, Head Office, and Major Competitors
    Table 36. Neurophth Biotechnology Major Business
    Table 37. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 38. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Neurophth Biotechnology Recent Developments and Future Plans
    Table 40. Belief BioMed Company Information, Head Office, and Major Competitors
    Table 41. Belief BioMed Major Business
    Table 42. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 43. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Belief BioMed Recent Developments and Future Plans
    Table 45. BiBo Biopharma Engineering Co., LTD. Company Information, Head Office, and Major Competitors
    Table 46. BiBo Biopharma Engineering Co., LTD. Major Business
    Table 47. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 48. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. BiBo Biopharma Engineering Co., LTD. Recent Developments and Future Plans
    Table 50. Beihai Kangcheng Company Information, Head Office, and Major Competitors
    Table 51. Beihai Kangcheng Major Business
    Table 52. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 53. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Beihai Kangcheng Recent Developments and Future Plans
    Table 55. PackGene Biotech Company Information, Head Office, and Major Competitors
    Table 56. PackGene Biotech Major Business
    Table 57. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 58. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. PackGene Biotech Recent Developments and Future Plans
    Table 60. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 61. Sarepta Therapeutics Major Business
    Table 62. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 63. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Sarepta Therapeutics Recent Developments and Future Plans
    Table 65. Carbon BioSciences Company Information, Head Office, and Major Competitors
    Table 66. Carbon BioSciences Major Business
    Table 67. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 68. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Carbon BioSciences Recent Developments and Future Plans
    Table 70. Kelonia Therapeutics Company Information, Head Office, and Major Competitors
    Table 71. Kelonia Therapeutics Major Business
    Table 72. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 73. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Kelonia Therapeutics Recent Developments and Future Plans
    Table 75. Roche Company Information, Head Office, and Major Competitors
    Table 76. Roche Major Business
    Table 77. Roche Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 78. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 79. Roche Recent Developments and Future Plans
    Table 80. Remedium Bio Company Information, Head Office, and Major Competitors
    Table 81. Remedium Bio Major Business
    Table 82. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
    Table 83. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 84. Remedium Bio Recent Developments and Future Plans
    Table 85. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue (USD Million) by Players (2019-2024)
    Table 86. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Share by Players (2019-2024)
    Table 87. Breakdown of Adeno-Associated Virus (AAV) Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 88. Market Position of Players in Adeno-Associated Virus (AAV) Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 89. Head Office of Key Adeno-Associated Virus (AAV) Gene Therapy Players
    Table 90. Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Type Footprint
    Table 91. Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Application Footprint
    Table 92. Adeno-Associated Virus (AAV) Gene Therapy New Market Entrants and Barriers to Market Entry
    Table 93. Adeno-Associated Virus (AAV) Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 94. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 95. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Share by Type (2019-2024)
    Table 96. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Forecast by Type (2025-2030)
    Table 97. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2024)
    Table 98. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Forecast by Application (2025-2030)
    Table 99. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 100. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 101. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 102. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 103. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 104. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 105. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 106. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 107. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 108. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 109. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 110. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 111. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 112. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 113. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 114. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 115. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 116. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 117. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 118. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 119. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 120. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 121. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 122. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 123. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 124. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 125. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 126. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 127. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 128. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 129. Adeno-Associated Virus (AAV) Gene Therapy Raw Material
    Table 130. Key Suppliers of Adeno-Associated Virus (AAV) Gene Therapy Raw Materials
List of Figures
    Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Picture
    Figure 2. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type in 2023
    Figure 4. Luxturna
    Figure 5. Zolgensma
    Figure 6. Others
    Figure 7. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application in 2023
    Figure 9. Central Nervous System Diseases Picture
    Figure 10. Ocular Diseases Picture
    Figure 11. Liver-directed Diseases Picture
    Figure 12. Other Hereditary Diseases Picture
    Figure 13. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Region in 2023
    Figure 18. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Share by Players in 2023
    Figure 24. Adeno-Associated Virus (AAV) Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Adeno-Associated Virus (AAV) Gene Therapy Market Share in 2023
    Figure 26. Global Top 6 Players Adeno-Associated Virus (AAV) Gene Therapy Market Share in 2023
    Figure 27. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Share by Type (2019-2024)
    Figure 28. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share Forecast by Type (2025-2030)
    Figure 29. Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Share by Application (2019-2024)
    Figure 30. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share Forecast by Application (2025-2030)
    Figure 31. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 65. Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
    Figure 66. Adeno-Associated Virus (AAV) Gene Therapy Market Restraints
    Figure 67. Adeno-Associated Virus (AAV) Gene Therapy Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Adeno-Associated Virus (AAV) Gene Therapy in 2023
    Figure 70. Manufacturing Process Analysis of Adeno-Associated Virus (AAV) Gene Therapy
    Figure 71. Adeno-Associated Virus (AAV) Gene Therapy Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio

Related Reports

Global Adeno-Associated Virus (AAV) Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Adeno-Associated Virus (AAV) Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 08 Jun 2023

date Service & Software

According to our (Global Info Research) latest study, the global Adeno-Associated Virus (AAV) Gene Therapy market size was valued at USD 1684.4 million in 2022 and is forecast to a readjusted size of USD 2966.6 million by 2029 with a CAGR of 8.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

date 08 Jun 2023

date Service & Software

The global Adeno-Associated Virus (AAV) Gene Therapy market size is expected to reach $ 2966.6 million by 2029, rising at a market growth of 8.4% CAGR during the forecast period (2023-2029).

Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2024-2030

Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2024-2030

date 28 Feb 2024

date Service & Software

The global Adeno-Associated Virus (AAV) Gene Therapy market size is expected to reach $ 2966.6 million by 2030, rising at a market growth of 8.4% CAGR during the forecast period (2024-2030).

Product Tags

Adeno-Associated Virus (AAV) Gene Therapy

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>